CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer

Zhang, ML; Wang, Q; Ding, Y; Wang, GQ; Chu, YQ; He, X; Wu, X; Shao, YW; Lu, KH

Lu, KH (reprint author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing, Jiangsu, Peoples R China.

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (11): 1792

Abstract

Introduction: Lung cancer is the leading cause of cancer-related deaths worldwide. ALK receptor tyrosine kinase gene (ALK) rearrangement has been iden......

Full Text Link